Baltimore study probes vaccine hesitancy in drug users
NCT ID NCT05769023
First seen Apr 28, 2026 · Last updated Apr 28, 2026
Summary
This study talks to 40 people who use opioids to learn why they might be hesitant about COVID-19 vaccines. Researchers want to understand barriers and improve HIV prevention in injection drug users. The study does not provide any treatment, only gathers opinions through a questionnaire.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland, 21205, United States
Conditions
Explore the condition pages connected to this study.